天智航(688277.SH):骨科手術導航定位系統取得醫療器械註冊證
格隆匯2月12日丨天智航(688277.SH)公佈,近日收到了由國家藥品監督管理局頒發的醫療器械註冊證,產品名稱:骨科手術導航定位系統。骨科手術機器人主要應用於關節置換手術、脊柱手術及骨科創傷手術。本次獲證產品適應證覆蓋頸椎、胸椎、腰椎、骶椎全節段脊柱外科手術和骨盆、髖臼、四肢等部位的創傷手術,以及全膝關節置換手術、全髖關節置換手術。上述醫療器械註冊證的取得,有利於豐富公司的產品種類,不斷滿足多元化的臨牀需求,提升公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.